Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
70,802.65
(
-3.11%
)
News Focus
News Focus

Replies to post #27343 on Ayala Pharmaceuticals Inc (fka ADXS)

Replies to #27343 on Ayala Pharmaceuticals Inc (fka ADXS)
icon url

DewDiligence

07/24/17 3:45 PM

#27353 RE: ignatiusrielly35 #27343

I'm talking about the relative slowness of a trial in the "adjuvant" setting, such as AIM2CERV, compared to a trial in the metastatic setting (where ADXS conducted its phase-2 trial in cervical cancer).